simvastatin has been researched along with Chagas Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Estrada, C; Carillo, I; Castillo, C; González-Herrera, F; Greif, G; Guzmán-Rivera, D; Kemmerling, U; Liempi, A; Maya, JD; Robello, C | 1 |
| Campos-Estrada, C; Ferreira, J; González-Herrera, F; Kemmerling, U; Lapier, M; Liempi, A; López-Muñoz, R; Maya, JD; Pesce, B | 1 |
2 other study(ies) available for simvastatin and Chagas Disease
| Article | Year |
|---|---|
Notch receptor expression in Trypanosoma cruzi-infected human umbilical vein endothelial cells treated with benznidazole or simvastatin revealed by microarray analysis.
Topics: Aspirin; Cells, Cultured; Chagas Disease; Gene Expression; HMGB1 Protein; Human Umbilical Vein Endothelial Cells; Humans; Nitroimidazoles; Receptor, Notch1; Simvastatin; Trypanosoma cruzi | 2020 |
Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.
Topics: Cell Adhesion Molecules; Cells, Cultured; Chagas Disease; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoxins; NF-kappa B; Nitroimidazoles; Signal Transduction; Simvastatin; Trypanocidal Agents | 2015 |